Charles River Laboratories | CRL - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.43B 2M 2026-06
Align Technology USD 864.87M 2.84M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Cardinal Health USD 62.86B 65.69B 2026-06
Charles River Laboratories USD 2.84B 1.96B 2026-06
Cigna USD 42.62B 410M 2026-06
Concord Medical Services Hldg CNY 354.58M 9.32M 2025-12
CVS Health USD 99.37B 3.62B 2026-06
Danaher USD 53.62B 1.04B 2026-09
Dentsply International USD 1.35B 33M 2026-06
Elevance Health USD 49.28B 4.39B 2026-09
Humana USD 39.51B 1.61B 2026-06
Illumina USD 899M 47M 2026-06
Incyte USD 973.64M 4.65B 2026-06
Intrexon USD 61.56M 26.1M 2024-06
IQVIA Holdings USD 3.82B 2.05B 2026-09
Laboratory Of America USD 3.39B 117.6M 2026-09
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Lonza CHF 2.9B 184M 2025-06
McKesson USD 103.96B 9.5B 2026-06
Merck EUR 4.34B 249M 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Novartis USD 10.2B 912M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Quest Diagnostics USD 2.62B 34M 2026-09
Revvity USD 603.55M 24.8M 2026-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
United Therapeutics USD 6.4B 499.2M 2026-06
UnitedHealth USD 106.35B 2.31B 2026-09
Veradigm USD 188M 61.08M 2022-12
Waters USD 527M 592M 2026-06
West Pharmaceutical Services USD 2.99B 200K 2026-06